Back to Search Start Over

Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study

Authors :
Sannemann, Lena
Schild, Ann-Katrin
Altenstein, Slawek
Bartels, Claudia
Brosseron, Frederic
Buerger, Katharina
Cosma, Nicoleta Carmen
Fliessbach, Klaus
Freiesleben, Silka Dawn
Glanz, Wenzel
Heneka, Michael T.
Janowitz, Daniel
Kilimann, Ingo
Kobeleva, Xenia
Laske, Christoph
Metzger, Coraline D.
Munk, Matthias H. J.
Perneczky, Robert
Peters, Oliver
Polcher, Alexandra
Priller, Josef
Rauchmann, Boris
Roesch, Christina
Rudolph, Janna
Schneider, Anja
Spottke, Annika
Spruth, Eike Jakob
Teipel, Stefan
Vukovich, Ruth
Wagner, Michael
Wiltfang, Jens
Wolfsgruber, Steffen
Duezel, Emrah
Jessen, Frank
Sannemann, Lena
Schild, Ann-Katrin
Altenstein, Slawek
Bartels, Claudia
Brosseron, Frederic
Buerger, Katharina
Cosma, Nicoleta Carmen
Fliessbach, Klaus
Freiesleben, Silka Dawn
Glanz, Wenzel
Heneka, Michael T.
Janowitz, Daniel
Kilimann, Ingo
Kobeleva, Xenia
Laske, Christoph
Metzger, Coraline D.
Munk, Matthias H. J.
Perneczky, Robert
Peters, Oliver
Polcher, Alexandra
Priller, Josef
Rauchmann, Boris
Roesch, Christina
Rudolph, Janna
Schneider, Anja
Spottke, Annika
Spruth, Eike Jakob
Teipel, Stefan
Vukovich, Ruth
Wagner, Michael
Wiltfang, Jens
Wolfsgruber, Steffen
Duezel, Emrah
Jessen, Frank
Publication Year :
2020

Abstract

BackgroundEarly identification of individuals at risk of dementia is mandatory to implement prevention strategies and design clinical trials that target early disease stages. Subjective cognitive decline (SCD) and neuropsychiatric symptoms (NPS) have been proposed as potential markers for early manifestation of Alzheimer's disease (AD). We aimed to investigate the frequency of NPS in SCD, in other at-risk groups, in healthy controls (CO), and in AD patients, and to test the association of NPS with AD biomarkers, with a particular focus on cognitively unimpaired participants with or without SCD-related worries.MethodsWe analyzed data of n=687 participants from the German DZNE Longitudinal Cognitive Impairment and Dementia (DELCODE) study, including the diagnostic groups SCD (n=242), mild cognitive impairment (MCI, n=115), AD (n=77), CO (n=209), and first-degree relatives of AD patients (REL, n=44). The Neuropsychiatric Inventory Questionnaire (NPI-Q), Geriatric Depression Scale (GDS-15), and Geriatric Anxiety Inventory (GAI-SF) were used to assess NPS. We examined differences of NPS frequency between diagnostic groups. Logistic regression analyses were carried out to further investigate the relationship between NPS and cerebrospinal fluid (CSF) AD biomarkers, focusing on a subsample of cognitively unimpaired participants (SCD, REL, and CO), who were further differentiated based on reported worries.ResultsThe numbers of reported NPS, depression scores, and anxiety scores were significantly higher in subjects with SCD compared to CO. The quantity of reported NPS in subjects with SCD was lower compared to the MCI and AD group. In cognitively unimpaired subjects with worries, low A ss 42 was associated with higher rates of reporting two or more NPS (OR 0.998, 95% CI 0.996-1.000, p<.05).ConclusionThese findings give insight into the prevalence of NPS in different diagnostic groups, including SCD and healthy controls. NPS based on informant report seem to be associated wit

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1238104374
Document Type :
Electronic Resource